Isoflavone supplementation plus combined aerobic and resistance exercise do not change phase angle values in postmenopausal women: A randomized placebo-controlled clinical trial
Related Experiment Video
Updated: Feb 5, 2026

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
Cinthia D Barbosa1, Juliene G Costa2, Jéssica S Giolo2
1School of Medicine, Federal University of Uberlandia (UFU), Uberlandia, MG, Brazil.
Objective:
The aim of this study was to evaluate the effect of isoflavone supplementation plus combined exercise protocol on phase angle (PhA) values in postmenopausal women.
Methods:
Thirty postmenopausal women were randomly assigned in a double blind, placebo-controlled clinical trial divided into two groups: 100 mg/day of isoflavone supplementation (n = 16) and 100 mg/day of starch (placebo; n = 14). In addition, both groups performed a combined aerobic and resistance exercise during 10 weeks. Body composition and PhA were evaluated by bioelectrical impedance.
Results:
PhA values did not change in the isoflavone group (PRE: 6.7 ± 0.7° to POST: 6.7 ± 0.6°) and in the placebo group (PRE: 7.2 ± 1.0° to POST: 6.8 ± 0.5°); p group = 0.304, p time = 0.227, p group x time interaction = 0.137. Additionally, delta values were not different (0.04 ± 0.5° vs. -0.40 ± 0.99°; p = 0.176) between isoflavone and placebo groups, respectively.
Conclusion:
We conclude that isoflavone supplementation plus combined aerobic and resistance exercise did not change PhA in postmenopausal women. The patients were part of ClinicalTrials.gov: NCT03008785.
Related Concept Videos
The Placebo Effect
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Phase-lead and Phase-lag Controllers
Statistical Software for Data Analysis and Clinical Trials
Biodiversity and Human Values

